Prof. Liu Xiaojun (刘晓军) — Robotic Gynecologic Oncology & Single-Port da Vinci Surgery | Changzheng Hospital Shanghai
In the rapidly evolving field of robotic gynecologic surgery, Prof. Liu Xiaojun (刘晓军) at Changzheng Hospital (Naval Medical University Second Affiliated Hospital) occupies a position of genuine historical distinction: he performed Asia's first 3rd-generation da Vinci robotic single-port laparoscopic gynecologic surgery — a milestone that places him at the frontier of minimally invasive gynecologic oncology not only in China but across the entire Asia-Pacific region. As Director of Obstetrics & Gynecology at Changzheng Hospital and a Shanghai Leading Talent, Prof. Liu has built his reputation on technical innovation, having developed and refined 5 new surgical techniques in robotic gynecologic surgery that have expanded the possibilities of minimally invasive approaches for patients with gynecologic cancers.
Specialty Focus
- Robotic gynecologic oncology surgery: cervical cancer, endometrial cancer, ovarian cancer
- da Vinci robotic single-port laparoscopic gynecologic surgery
- Minimally invasive radical hysterectomy and lymphadenectomy
- Robotic fertility-sparing gynecologic surgery
- Complex gynecologic tumor resection using robotic platforms
- Surgical innovation in minimally invasive gynecologic oncology
Academic & Clinical Titles
- Chief Physician & Professor, Director of Obstetrics & Gynecology, Changzheng Hospital, Naval Medical University (Second Military Medical University)
- Shanghai Leading Talent (上海领军人才)
- Performer of Asia's first 3rd-generation da Vinci robotic single-port laparoscopic gynecologic surgery
- Innovator of 5 new surgical techniques in robotic gynecologic oncology
Asia's First: 3rd-Generation da Vinci Single-Port Robotic Surgery
The da Vinci Surgical System has transformed minimally invasive surgery across multiple specialties, offering surgeons enhanced three-dimensional visualization, wristed instrument articulation, and tremor filtration that enable complex operations to be performed through small incisions with precision that exceeds what is possible with conventional laparoscopy. The 3rd-generation da Vinci SP (Single Port) system — which performs the entire operation through a single small incision — represents the most advanced iteration of this technology, offering the benefits of robotic surgery with even less surgical trauma, reduced scarring, and faster recovery than multi-port robotic approaches.
Prof. Liu Xiaojun's performance of Asia's first 3rd-generation da Vinci single-port laparoscopic gynecologic surgery is not merely a symbolic milestone. It reflects his position at the leading edge of robotic surgical adoption in Asia — his team's early mastery of this technology means that his patients benefit from the accumulated experience of a program that has been working with the most advanced robotic platforms longer than virtually any other center in the region.
For patients with gynecologic cancers who are candidates for minimally invasive surgery, Prof. Liu's robotic program offers the most technically advanced approach available in Shanghai — with the potential for smaller incisions, less blood loss, shorter hospital stay, faster return to normal activities, and reduced risk of wound complications compared to open surgery.
Five Innovative Surgical Techniques
Beyond his pioneering adoption of new robotic platforms, Prof. Liu has developed and refined 5 new surgical techniques in robotic gynecologic oncology. Surgical innovation of this kind — identifying limitations in existing approaches and developing systematic solutions — reflects a level of technical mastery and creative thinking that distinguishes the most accomplished surgeons from those who simply apply established methods.
These innovations address specific technical challenges in robotic gynecologic surgery: improving access to difficult anatomical locations, reducing operative time, enhancing oncological clearance, minimizing damage to adjacent structures, or enabling minimally invasive approaches in cases that would otherwise require open surgery. The development of 5 distinct new techniques over the course of a career represents a substantial contribution to the field — one that benefits not only Prof. Liu's own patients but the broader community of surgeons who adopt these approaches.
Robotic Surgery for Gynecologic Cancers: Clinical Applications
Cervical cancer: Robotic radical hysterectomy with pelvic lymphadenectomy is the minimally invasive alternative to open radical hysterectomy for early-stage cervical cancer. Prof. Liu's robotic approach offers the precision required for the careful dissection of the parametrium, ureter, and bladder that is central to radical hysterectomy — with the enhanced visualization and instrument control of the da Vinci system reducing the risk of urological complications. Robotic radical trachelectomy (fertility-sparing) is also performed for selected patients.
Endometrial cancer: Robotic surgical staging — including hysterectomy, bilateral salpingo-oophorectomy, and pelvic/para-aortic lymphadenectomy — is the standard minimally invasive approach for endometrial cancer. The robotic platform is particularly advantageous for obese patients, in whom conventional laparoscopy is technically more challenging. Sentinel lymph node mapping with robotic assistance is increasingly used to reduce the morbidity of full lymphadenectomy.
Ovarian cancer: Selected cases of early-stage ovarian cancer and ovarian cystic lesions can be managed with robotic minimally invasive approaches. For advanced ovarian cancer requiring cytoreductive surgery, the robotic platform can facilitate access to difficult anatomical locations including the diaphragm, paracolic gutters, and pelvis.
Recurrent gynecologic cancers: Robotic surgery for recurrent disease — in a pelvis that has often been altered by prior surgery and/or radiation — requires the highest level of technical skill. Prof. Liu's extensive robotic experience makes him one of the surgeons best equipped to manage these technically demanding cases.
Changzheng Hospital: Military Medical Excellence
Changzheng Hospital — the Second Affiliated Hospital of Naval Medical University (formerly Second Military Medical University) — is one of Shanghai's major academic medical centers, with a tradition of clinical excellence rooted in its military medical heritage. The hospital's Department of Obstetrics & Gynecology, which Prof. Liu directs, has comprehensive capabilities in gynecologic oncology surgery, supported by advanced robotic surgical infrastructure, pathology, and multidisciplinary oncology services.
For international patients, Changzheng Hospital's robotic surgery program — one of the most advanced in Shanghai — provides access to the full range of da Vinci robotic platforms, including the 3rd-generation SP system with which Prof. Liu has pioneering experience.
Who Should Consider Consulting Prof. Liu Xiaojun
- Patients with cervical cancer who prefer minimally invasive robotic surgery over open radical hysterectomy
- Patients with endometrial cancer seeking robotic surgical staging, including obese patients for whom conventional laparoscopy is more challenging
- Patients with ovarian cancer or complex ovarian lesions suitable for minimally invasive management
- Patients who have been told minimally invasive surgery is not possible for their case and want a second opinion from a robotic surgery specialist
- Patients seeking fertility-sparing robotic surgery for early-stage gynecologic cancers
- Patients with recurrent gynecologic cancers requiring complex surgical re-intervention
How CMCS Connects You with Prof. Liu Xiaojun
China Medical Concierge Shanghai (CMCS) facilitates access to Prof. Liu Xiaojun for international patients with gynecologic cancers seeking robotic minimally invasive surgery. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including pathology reports, MRI pelvis, CT chest/abdomen/pelvis, tumor markers, and prior treatment summaries. Prof. Liu's team can conduct an initial remote assessment of robotic surgery candidacy before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation robotic surgery candidacy assessment
- Appointment coordination with Prof. Liu Xiaojun at Changzheng Hospital Shanghai
- On-site interpretation during consultations and procedures
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Prof. Liu Xiaojun
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 comentarios